NQO1 and liver cancer: After competitively binding to KEAP1, P62 can promote an increase of Nrf2 expression, activate the expression of its downstream related molecules (including NQO1, HO1 and FTH1, etc.), inhibit the apoptosis of liver cancer cells induced by iron accumulation, and may participate in promoting the continuous progression of liver cancer (5).